Navamedic ASA
The answer first
Does Navamedic beat the market?
No, Navamedic has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 15% of Nordic stocks
- Quality12
- Value75
- Trend8
No. 147 of 195 in healthcare
Expectations in the price
Moderate expectations
For the share to return about 9% a year from today's price, the cash Navamedic keeps must grow about 6% a year for 10 years.
Max for seven days
Follow Navamedic with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Navamedic
Your first answer is free, no account needed.
Do you own Navamedic, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Navamedic and a few more. Free, no card.
Super Stock+46.4%In short
- Navamedic has fallen 51.9% over the past year, including dividends.
- Overall, Navamedic ranks better than 15% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 74.2%. The price is 75.7% below its peak now.
Who owns Navamedic? See the major shareholders and their stakes
What do analysts think of Navamedic?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 15% of Nordic stocks.
No. 147 of 195 in healthcare
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 183 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.55
- Asset turnoverSales divided by everything the company owns0.87
- Return on equityProfit divided by equity−7.6%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
High Low price: you pay little for what the company earns and owns.
No. 16 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.8
- P/SPrice divided by sales0.4
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flow5.9
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 161 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−30.8%
- 6 months−41.7%
- 9 months−51.6%
- 12 months−51.9%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Navamedic
Navamedic ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 38 employees.
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.


See the full analysis of Navamedic.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card